REG - AstraZeneca PLC - Annual Financial Report <Origin Href="QuoteRef">AZN.L</Origin> - Part 7

AstraZenecaAnnouncement

10/03/2015 11:01

- Part 7: For the preceding part double click  ID:nRSJ0188Hf 

                                                                                                                                                                                                                                     
 
 
APPENDIX B 
 
This statement relates to and is extracted from the Annual Report. It is
repeated here solely for the purpose of complying with DTR 6.3.5. It is not
connected to the information presented in this announcement or in the
Company's fourth quarter and full year results 2014 announcement that was
published on 5 February 2015. 
 
Directors' responsibility statement pursuant to DTR 4 
 
The Directors confirm that to the best of our knowledge: 
 
·     The Financial Statements, prepared in accordance with the applicable set
of accounting standards, give a true and fair view of the assets, liabilities,
financial position and profit or loss of the Company and the undertakings
included in the consolidation taken as a whole. 
 
·     The Directors' Report includes a fair review of the development and
performance of the business and the position of the issuer and the
undertakings included in the consolidation taken as a whole, together with a
description of the principal risks and uncertainties that they face. 
 
On behalf of the Board of Directors on 5 February 2015 
 
Pascal Soriot 
 
Director 
 
APPENDIX C 
 
Related party transactions 
 
The Group had no material related party transactions which might reasonably be
expected to influence decisions made by the users of these Financial
Statements. 
 
This information is provided by RNS
The company news service from the London Stock Exchange